Back to Authors

Emberley, Katie

https://orcid.org/0000-0003-2333-2289

Mayo Clinic

Oregon Health & Science University

Citations 1

Elevated α5 integrin expression on myeloid cells in motor areas in amyotrophic lateral sclerosis is a therapeutic target
Chiot, Aude , Roemer, Shanu F. , Ryner, Lisa, Bogachuk, Alina, Emberley, Katie , Brownell, Dillon , Jiménez, G. , Leviten, Michael, Woltjer, Randall L. , Steinman, Lawrence , Ajami, Bahareh , Steinman, Lawrence , Ajami, Bahareh , Dickson, Dennis W.

Proceedings of the National Academy of Sciences | July 31, 2023 | Volume: 120 | Issue: 32 | Pages: No page available

10.1073/pnas.2306731120 Get It

Amyotrophic lateral sclerosis (ALS) is a fatal disease affecting upper and lower motor neurons. Microglia directly interact with motor neurons and participate in the progression of ALS. Single-cell mass cytometry (CyTOF) analysis revealed prominent expression of α5 integrin in microglia and macrophages in a superoxide dismutase-1 G93A mouse model of ALS (SOD1 G93A ). In postmortem tissues from ALS patients with various clinical ALS phenotypes and disease duration, α5 integrin is prominent in motor pathways of the central and peripheral nervous system and in perivascular zones associated with the blood–brain barrier. In SOD1 G93A mice, administration of a monoclonal antibody against α5 integrin increased survival compared to an isotype control and improved motor function on behavioral testing. Together, these findings in mice and in humans suggest that α5 integrin is a potential therapeutic target in ALS.